UMN Pharma Inc. | Balance Sheet
Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,268
2,080
842
566
1,734
1,018
Total Accounts Receivable
789
165
185
18
27
23
Inventories
179
687
2,103
-
63
20
Other Current Assets
160
265
174
66
12
16
Total Current Assets
5,396
3,197
3,304
650
1,837
1,077
Net Property, Plant & Equipment
12,827
9,171
8,136
-
-
81
Total Investments and Advances
67
67
56
44
44
-
Long-Term Note Receivable
300
200
100
-
-
-
Intangible Assets
411
246
172
-
-
-
Other Assets
-
1
1
40
10
19
Total Assets
19,002
12,882
11,808
694
1,891
1,177
ST Debt & Current Portion LT Debt
4,288
1,037
4,825
25
-
Accounts Payable
-
-
343
-
-
Income Tax Payable
30
31
22
36
1
Other Current Liabilities
410
732
140
61
45
Total Current Liabilities
4,728
1,799
5,330
122
47
Long-Term Debt
9,424
6,787
5,562
-
1,460
Provision for Risks & Charges
168
171
175
23
23
Deferred Taxes
56
54
48
-
-
Other Liabilities
372
366
360
340
4
Total Liabilities
14,748
9,177
11,475
486
1,534
Common Equity (Total)
4,209
3,705
334
209
357
Total Shareholders' Equity
4,209
3,705
334
209
357
Total Equity
4,253
3,705
334
209
357
Liabilities & Shareholders' Equity
19,002
12,882
11,808
694
1,891
Accumulated Minority Interest
45
-
-
-
-
About UMN Pharma
View Profile
